Alder Therapeutics Is A Biotechnology Company Founded In 2022With A Mission Tocure The Incurablethrough The Development Of Pluripotent Stem Cellpsctherapiesthe Company Aims To Overcome Challenges In Traditional Psc Therapy Development By Focusing On Robust Manufacturing Processes And Commercial Viability Assessmentsthis Approach Ensures That Their Therapies Are Both Effective And Commercially Sustainable Alder Therapeutics Is Developing Two Allogeneic Stem Cell Therapiesald01Aimed At Treating Retinitis Pigmentosaand Ald02Which Targets Chronic Heart Failureald01 Has Shown Promising Results In Preclinical Studieswhile Ald02 Has Demonstrated Improvements In Heart Function Without Causing Serious Side Effectsthe Company Has Raised A 3 Million In Seed Funding And Is Seeking Additional Investment To Advance Its Programs
